Former Horizon Therapeutics chairman & CEO brings 30 years of biopharmaceutical industry experience Walbert led recent acquisition of Horizon Therapeutics by Amgen for $28.3 billion THOUSAND OAKS, Calif., Nov. 19, 2024 /PRNewswire/ — Latigo Biotherapeutics (“Latigo”), a clinical-stage…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.